NCT04825275 2026-01-23
Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial
Milton S. Hershey Medical Center
Phase EARLY_PHASE1 Terminated
Clinical Trials
10 trialsNCT04869449 2026-01-07
Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
Milton S. Hershey Medical Center
Phase EARLY_PHASE1 Terminated
NCT04424966 2025-10-24
Infigratinib in Recurrent High-Grade Glioma Patients
St. Joseph's Hospital and Medical Center, Phoenix
Phase EARLY_PHASE1 Terminated
NCT04712721 2025-10-10
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
Novartis
Phase EARLY_PHASE1 Terminated
NCT04074785 2025-08-17
SCCC-06319
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT04221061 2024-06-17
18F-FluorThanatrace (PET/CT) in Glioblastoma
University of Pennsylvania
Phase EARLY_PHASE1 Terminated
NCT03151772 2020-09-28
INSIDE
Sahlgrenska University Hospital
Phase EARLY_PHASE1 Terminated
NCT01086345 2018-07-03
Radiosurgery Plus Bevacizumab in Glioblastoma
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT01996527 2017-04-17
3T MRI Biomarkers of Glioma Treatment Response
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Terminated
NCT01105988 2012-01-06
Evaluating Tumor Pseudoprogression With FLT-PET and MRI
Massachusetts General Hospital
Phase EARLY_PHASE1 Terminated